Abstract Coronavirus disease-2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), may predispose patients …

2 METHODS This guidance statement is a collaborative effort of the Perioperative and
Critical Care Thrombosis and Haemostasis Subcommittee, along with members of the …

Hemodynamic instability and right ventricular (RV) dysfunction are the key determinants of
short-term prognosis in patients with acute pulmonary embolism (PE). High-risk PE …

The role of echocardiography in acute pulmonary embolism (PE) remains incompletely
defined. Echocardiography cannot reliably diagnose acute PE, and it does not improve …

Тромбоэмболия легочной артерии (ТЭЛА) является третьим по распространенности
сердечно-сосудистым заболеванием (расчетная заболеваемость в Европе и США …

Background Right ventricle dysfunction (RVD) at echocardiography predicts mortality in
patients with acute pulmonary embolism (PE), but heterogeneous definitions of RVD have …

Aims Pulmonary embolism severity index (PESI) has been developed to help physicians
make decisions about the treatment of patients with pulmonary embolism (PE). The …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is commonly
associated with myocardial injury and heart failure. The pathophysiology behind this …

Intermediate-risk pulmonary embolism (PE) has variable outcomes. Current risk stratification
models lack the positive predictive value to identify patients at highest risk of PE-related …

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been an
unprecedented global health problem, causing more than 20 million infections and more …